Trial intelligence / Profile preview

Intrapleural sodium bicarbonate for acute empyema and complicated parapneumonic effusions

jRCTs031240093Recruiting

Start
Oct 2024
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of sodium bicarbonate in empyema and parapneumonic effusion. Primary endpoint: Avoidance of surgery or death. Started Oct 2024; status: recruiting.

02

Drugs

sodium bicarbonate
03

Conditions

empyemaparapneumonic effusion

Beyond the preview

Go deeper on jRCTs031240093.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031240093.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call